PATHOPHYSIOLOGY OF DIALYSIS DISEQUILIBRUM SYNDROME
透析失衡综合征的病理生理学
基本信息
- 批准号:2144869
- 负责人:
- 金额:$ 19.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-09-30 至 1997-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Currently, more than 200,000 patients in the United States are treated
for end stage renal disease (ESRD). Among them, about 60% are treated
with hemodialysis. These patients frequently suffer from dialysis
disequilibrium syndrome (DDS) which includes symptoms varying from
seizure and coma to muscle cramps, anorexia, and restlessness. DDS is
caused by brain edema when uremia is corrected too rapidly with
hemodialysis. It has been debated whether brain edema is due to the
retention of urea in the brain or due to the generation of unknown
molecules, so-called "idiogenic osmoles" after hemodialysis. In either
case, water would be shifted into the brain to cause brain edema. Since
these "idiogenic osmoles" have not been identified, the real mechanisms
of DDS remain unclear. As a result, proper ways to diagnose and to treat
DDS have not yet been established. Previously, the investigators have
successfully identified the dehydration-induced "idiogenic osmoles" in
the rat brain by using 1H-nuclear magnetic resonance (NMR) spectroscopy
and other biochemistry methods. They propose to use the similar
approaches to characterize the "idiogenic osmoles" responsible to the
development of DDS. Furthermore, they will apply the advanced NMR
techniques, such as magnetic resonance imaging and localized NMR
spectroscopy, to observe the changes of these "idiogenic osmoles" and
associated changes in cell size, cell energy level, acid content and
other metabolites in the brain and thigh muscle of living animals during
the course of hemodialysis. To further delineate the role of different
types of brain cells on the development of DDS, investigators will study
the effects of addition and subsequent withdrawal of urea on cultured
brain cells of a single cell type in a NMR-compatible system recently
developed by them. The molecular basis of the generation of "idiogenic
osmoles" will also be investigated in these cultured brain cells. These
results would shed light on the mechanisms of DDS and provide information
of the metabolic consequence of ESRD and hemodialysis. Potentially, new
methods of diagnosing, treating and preventing DDS may be developed,
thus, the quality of life of hemodialysis patients will be significantly
improved.
目前,美国有超过20万名患者接受治疗
终末期肾病(ESRD) 其中,约60%的人接受治疗
血液透析。这些患者经常遭受透析
不平衡综合征(DDS),包括以下症状
癫痫和昏迷到肌肉痉挛厌食和坐立不安 DDS是
由于尿毒症纠正过快而引起脑水肿,
血液透析。 关于脑水肿是否是由于
尿素在脑中的滞留或由于产生未知的
分子,即血液透析后所谓的“特发性渗透压”。 在任一
在这种情况下,水会转移到大脑中,导致脑水肿。 以来
这些“特发性渗透压”尚未确定,其真实的机制
DDS的情况仍不清楚。 因此,正确的诊断和治疗方法
DDS尚未建立。 此前,调查人员已经
成功鉴定了脱水诱导的“特发性渗透压”,
用1H-核磁共振(NMR)波谱法测定大鼠脑
和其他生物化学方法。 他们建议使用类似的
方法来表征“独特的渗透压”负责
DDS的发展。 此外,他们将应用先进的核磁共振技术,
技术,例如磁共振成像和局部核磁共振
光谱法,观察这些“自发渗透压摩尔”的变化,
在细胞大小、细胞能量水平、酸含量和
其他代谢物在活体动物的大脑和大腿肌肉中,
血液透析的过程。 为了进一步阐明不同的
类型的脑细胞对DDS的发展,研究人员将研究
添加和随后取消尿素对培养的
最近,在NMR兼容系统中的单个细胞类型的脑细胞
由他们开发的。 “特基因”产生的分子基础
还将在这些培养的脑细胞中研究”渗透压“。 这些
结果将揭示DDS的机制,并提供信息
终末期肾病和血液透析的代谢后果。 可能,新
可以开发诊断、治疗和预防DDS的方法,
因此,血液透析患者的生活质量将显著提高,
提高
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YEONG-HAU H. LIEN其他文献
YEONG-HAU H. LIEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YEONG-HAU H. LIEN', 18)}}的其他基金
CHIMERIC RNA/DNA OLIGONUCLEOTIDE BASED GENE THERAPY
基于嵌合 RNA/DNA 寡核苷酸的基因治疗
- 批准号:
6363057 - 财政年份:2000
- 资助金额:
$ 19.16万 - 项目类别:
CHIMERIC RNA/DNA OLIGONUCLEOTIDE BASED GENE THERAPY
基于嵌合 RNA/DNA 寡核苷酸的基因治疗
- 批准号:
6517673 - 财政年份:2000
- 资助金额:
$ 19.16万 - 项目类别:
CHIMERIC RNA/DNA OLIGONUCLEOTIDE BASED GENE THERAPY
基于嵌合 RNA/DNA 寡核苷酸的基因治疗
- 批准号:
6635203 - 财政年份:2000
- 资助金额:
$ 19.16万 - 项目类别:
CHIMERIC RNA/DNA OLIGONUCLEOTIDE BASED GENE THERAPY
基于嵌合 RNA/DNA 寡核苷酸的基因治疗
- 批准号:
6027646 - 财政年份:2000
- 资助金额:
$ 19.16万 - 项目类别:
KIDNEY SPECIFIC, LIPOSOME/POLYCATION MEDIATED THERAPY
肾脏特异性脂质体/聚阳离子介导治疗
- 批准号:
2905974 - 财政年份:1997
- 资助金额:
$ 19.16万 - 项目类别:
KIDNEY SPECIFIC, LIPOSOME/POLYCATION MEDIATED THERAPY
肾脏特异性脂质体/聚阳离子介导治疗
- 批准号:
2017873 - 财政年份:1997
- 资助金额:
$ 19.16万 - 项目类别:
KIDNEY SPECIFIC, LIPOSOME/POLYCATION MEDIATED THERAPY
肾脏特异性脂质体/聚阳离子介导治疗
- 批准号:
2701233 - 财政年份:1997
- 资助金额:
$ 19.16万 - 项目类别:
PATHOPHYSIOLOGY OF DIALYSIS DISEQUILIBRUM SYNDROME
透析失衡综合征的病理生理学
- 批准号:
2016577 - 财政年份:1992
- 资助金额:
$ 19.16万 - 项目类别:
PATHOPHYSIOLOGY OF DIALYSIS DISEQUILIBRUM SYNDROME
透析失衡综合征的病理生理学
- 批准号:
2144870 - 财政年份:1992
- 资助金额:
$ 19.16万 - 项目类别:
PATHOPHYSIOLOGY OF DIALYSIS DISEQUILIBRUM SYNDROME
透析失衡综合征的病理生理学
- 批准号:
3247177 - 财政年份:1992
- 资助金额:
$ 19.16万 - 项目类别:
相似海外基金
Development of small extracellular vesicle agent against brain edema after stroke
抗脑卒中后脑水肿小细胞外囊泡剂的研制
- 批准号:
22K09256 - 财政年份:2022
- 资助金额:
$ 19.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Ethanol disturbes inchemic brain edema
乙醇扰乱缺血性脑水肿
- 批准号:
18K10125 - 财政年份:2018
- 资助金额:
$ 19.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathophysiological investigation of cytokines and chemokines playing a role in the mechanism of developing brain edema
细胞因子和趋化因子在脑水肿发生机制中的病理生理学研究
- 批准号:
18K17417 - 财政年份:2018
- 资助金额:
$ 19.16万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of novel astrocyte-targeted drugs against brain edema and neuronal injury
开发针对脑水肿和神经元损伤的新型星形胶质细胞靶向药物
- 批准号:
18K06695 - 财政年份:2018
- 资助金额:
$ 19.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Using RNAi techniques, practical use for control of brain edema with aquaporin regulation
利用RNAi技术,通过水通道蛋白调节控制脑水肿的实际应用
- 批准号:
18K08835 - 财政年份:2018
- 资助金额:
$ 19.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Preventing brain edema involved with astrocyte expansion due to its potassium intake
预防与星形胶质细胞因摄入钾而扩张有关的脑水肿
- 批准号:
17K11583 - 财政年份:2017
- 资助金额:
$ 19.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of the brain edema therapeutics based on a characteristic for AQP11
基于AQP11特性的脑水肿疗法的开发
- 批准号:
17K10851 - 财政年份:2017
- 资助金额:
$ 19.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suppressive effects of GOREI-SAN (Kampo) for brain edema and inflammatory response in acute phase after status epilepticus
GOREI-SAN(汉方)对癫痫持续状态急性期脑水肿和炎症反应的抑制作用
- 批准号:
17K08356 - 财政年份:2017
- 资助金额:
$ 19.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a new therapy for brain edema: study for regulation of AQP4 as a molecular target
脑水肿新疗法的开发:以 AQP4 作为分子靶标的调节研究
- 批准号:
15H04688 - 财政年份:2015
- 资助金额:
$ 19.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Clinical use of functional regulation of aquaporin for brain edema decrease using knockdown technique
敲低技术水通道蛋白功能调节减轻脑水肿的临床应用
- 批准号:
15K10526 - 财政年份:2015
- 资助金额:
$ 19.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)